semaglutide and hormone replacement therapy progesterone PSA for all the women on GLP-1s (HRT) semaglutide and hormone replacement therapy

KFFs November 2025 Health Tracking Poll found that 12% of US adults are currently taking a GLP-1double the 6% who said so 18 months earlierand that side effects are now nearly as common a reason for stopping as cost (13% vs

They act on the hormones that influence feelings of hunger and satiety, helping you make balanced choices naturally

When follicles mature, the body produces more androgens due to increased relative luteinizing hormone (LH) [38]

The global GLP-1 receptor agonist market size is valued at USD 53.5 billion in 2024 and is expected to grow to USD 62.86 billion by 2025

Unexpected symptoms after using an unverified product may come from the claimed ingredient, an incorrect dose, contamination, or a completely different substance

PMC 5349816